Tag Archives: Hepatitis C Drugs Industry

Hepatitis C Drugs Market to Perceive an Aggrandizing Growth by 2023: Prognosticates MRFR

Hepatitis is inflammation of the liver characterized by yellowed eyes and skin due to bilirubin, flu-like symptoms which include nausea, vomiting, poor appetite, joint pain, headaches, clay colored stools etc. Hepatitis is caused by a variety of factors both microbial and non-microbial. However hepatitis C is caused by hepatitis C virus and affects between 130–150… Read More »